http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2372077-B2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f11ac5ada799060f8c2e97b1ee47b80d |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-453 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-453 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
| filingDate | 2010-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2012-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eee61e6469c75d2a947c1268b8f2d9af http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f49f7c77b5babcb4f03e623c8aa8fa2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e874095d02b2ad5c8ad2c852a2e5836 |
| publicationDate | 2012-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2372077-B2 |
| titleOfInvention | USE OF RAPAMYCIN FOR THE TREATMENT OF COGNITIVE DEFICITS ASSOCIATED WITH THE DOWN SYNDROME. |
| abstract | Use of rapamycin for the treatment of cognitive deficits associated with Down syndrome. # The present invention relates to the use of a composition comprising an inhibitor of the mTOR protein, wherein that inhibitor is selected from rapamycin, temsirolimus, everolimus or deforolimus . Furthermore, the present invention relates to the use of these inhibitors, and preferably rapamycin, for the manufacture of a medicament for the treatment of cognitive deficit associated with Down syndrome. |
| priorityDate | 2010-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 135.